Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials Post author:Sam Post published:March 4, 2018 Post category:BioPharma Dermira plans to shutter the program and move on to more promising compounds. Source: BioSpace You Might Also Like Laurus Labs PAT Grows By 40%; Board Recommends A Dividend Of 15% May 18, 2017 FDA Finally Allows 23andMe to Sell At-Home DNA Tests for 10 Diseases April 6, 2017 Worldwide Clinical Trials Selects " As New Head Of Global Business Development March 29, 2017
